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Abstract
Background: Deoxynucleoside triphosphates (dNTPs) are the normal substrates for DNA synthesis catalyzed by polymerases
such as HIV-1 reverse transcriptase (RT). However, substantial amounts of deoxynucleoside diphosphates (dNDPs) are also
present in the cell. Use of dNDPs in HIV-1 DNA synthesis could have significant implications for the efficacy of nucleoside RT
inhibitors such as AZT which are first line therapeutics for treatment of HIV infection. Our earlier work on HIV-1 reverse
transcriptase (RT) suggested that the interaction between the c-phosphate of the incoming dNTP and RT residue K65 in the
active site is not essential for dNTP insertion, implying that this polymerase may be able to insert dNDPs in addition to
dNTPs.
Methodology/Principal Findings:We examined the ability of recombinant wild type (wt) and mutant RTs with substitutions
at residue K65 to utilize a dNDP substrate in primer extension reactions. We found that wild type HIV-1 RT indeed catalyzes
incorporation of dNDP substrates whereas RT with mutations of residue K65 were unable to catalyze this reaction. Wild type
HIV-1 RT also catalyzed the reverse reaction, inorganic phosphate-dependent phosphorolysis. Nucleotide-mediated
phosphorolytic removal of chain-terminating 39-terminal nucleoside inhibitors such as AZT forms the basis for HIV-1
resistance to such drugs, and this removal is enhanced by thymidine analog mutations (TAMs). We found that both wt and
TAM-containing RTs were able to catalyze Pi-mediated phosphorolysis of 39-terminal AZT at physiological levels of Pi with
an efficacy similar to that for ATP-dependent AZT-excision.
Conclusions: We have identified two new catalytic functions of HIV-1 RT, the use of dNDPs as substrates for DNA synthesis,
and the use of Pi as substrate for phosphorolytic removal of primer 39-terminal nucleotides. The ability to insert dNDPs has
been documented for only one other DNA polymerase, the RB69 DNA polymerase and the reverse reaction employing
inorganic phosphate has not been documented for any DNA polymerase. Importantly, our results show that Pi-mediated
phosphorolysis can contribute to AZT resistance and indicates that factors that influence HIV resistance to AZT are more
complex than previously appreciated.
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Introduction
DNA polymerases are responsible for replicating and repairing
an organism’s genome (reviewed in [1]). Polymerases responsible
for replication have properties that are different from those
responsible for repair. Replicative polymerases are accurate and
processive (multiple nucleotide incorporations) in their DNA
synthesis, whereas repair polymerases are less accurate and
distributive (insertion of single, or a few nucleotides). HIV-1, the
causative agent of AIDS, uses a specialized DNA polymerase for
its replication. This DNA polymerase is a reverse transcriptase,
and is capable of synthesizing a DNA strand from either a DNA or
RNA template. HIV-1 reverse transcriptase (RT) is a replicative
DNA polymerase, but has a fidelity (the accuracy with which it
copies the template strand) that is intermediate between typical
replicative and repair polymerases [2,3]. In common with all
polymerases, the nucleotide to be added to the nascent DNA chain
forms many interactions with the polymerase. These interactions
include contacts between RT and portions of the incoming
nucleotide distinct from the base [4], which stabilize the nucleotide
in the active site without sequence specificity, although the
interactions may influence polymerase fidelity. Recent results from
our laboratory and others have demonstrated that one such
interaction, between the K65 residue of RT and the c-phosphate
of the incoming nucleotide is not absolutely required for
polymerase activity. Abolition of the interaction by deleting
residues 65–69 in the fingers subdomain of the RT, or by point
mutation of the K65 residue that interacts with the c-phosphate,
resulted in RT that retained activity, albeit much less than the wild
type enzyme [5,6]. The non-essential nature of this interaction
suggests that the c-phosphate of the incoming nucleotide may be
dispensable, and therefore that a nucleoside diphosphate may be
utilized as a substrate by RT.
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Deoxynucleoside diphosphates are naturally present in the cell
as an intermediate in the de novo synthesis of deoxynucleotide
triphosphates [7]. The relative concentration of the nucleoside
diphosphate compared to the triphosphate depends on the cellular
localization; for example, more TDP than TTP is detected in the
mitochondrial fraction, however, approximately 80% of cytosolic
thymidine is present as TTP and 20% as TDP [8]. Utilization of a
nucleoside diphosphate substrate by template-dependent polymer-
ases is very unusual. To our knowledge, only one example of such
a polymerase has been reported, phage RB69 DNA polymerase
gp43 [9]. RB69 gp43 is a replicative DNA polymerase from
polymerase family B, as distinct from the polymerase A family
member, the E. coli DNA polymerase I, which is a repair
polymerase [10].
Pyrophosphorolysis, the reverse reaction of polymerization, is the
pyrophosphate-dependent excision of the 39-terminal nucleotide
from a DNA chain, and results in the release of this terminal
nucleotide as a nucleoside triphosphate. The reverse reaction of
polymerization utilizing dADP as a substrate would be inorganic
phosphate-dependent phosphorolysis. Pyrophosphorolysis and nu-
cleoside dependent phosphorolysis have a particular importance in
the susceptibility of HIV-1 to nucleoside analog drugs, as RT
mutations (thymidine analog mutations; TAMs) that increase the
efficiency of these processes are responsible for the resistance of
HIV-1 to thymidine analogs such as AZT [11,12]. Clinically
significant TAMs include combinations of M41L, D67N, K70R,
T215F/Y, and K219Q. Wild-type HIV-1 RT can catalyze the
removal of a chain-terminating dideoxynucleotide by either
pyrophosphorolysis or nucleotide (ATP)-dependent phosphorolysis
[11]. Introduction of TAMs increases RT-catalyzed ATP-depen-
dent removal of chain-terminating NRTIs as well as reducing the
inhibition of NRTI removal by the next complementary nucleotide
[13]. Mutations of residues 67 and 70, both in the fingers subdomain
and near residue K65 (Fig. 1A), were found to have the greatest
effect on increasing unblocking [13], while a T215F substitution in
the palm subdomain is largely responsible for the reduced inhibition
by the next complementary nucleotide [14]. TAMs have a much
smaller impact on the rate of pyrophosphorolysis than on the rate of
ATP-mediated phosphorolysis [12,13,15].
In this report, we show for the first time that one of the most
extensively studied DNA polymerases, HIV-1 RT, is in fact able to
use deoxynucleoside diphosphates as a substrate for DNA
synthesis. Importantly, we also show that RT catalyzes the reverse
reaction, phosphorolytic removal of primer 39-nucleotides medi-
ated by inorganic phosphate (Pi). This latter observation has
significant impact on the continued utility of nucleoside analog
drugs as first line therapeutics for HIV-1 infection.
Results
HIV-1 RT can catalyze the insertion of deoxynucleoside
diphosphates
In order to test the hypothesis that HIV-1 RT can utilize a
nucleoside diphosphate substrate, we performed a single nucleo-
tide extension assay with dADP on a DNA.DNA template primer.
Extension of the 59 radiolabeled primer by a single nucleotide was
detected, and the reaction displayed typical Michaelis-Menten
kinetics (Km of 9.961.6 mM, kcat 0.0260.001 min21, kcat/Km
0.002 mM21 min21) (Fig. 2A). These values are to be compared
with the kinetic constants that we previously published [5] for
single nucleotide extension utilizing dATP and the same template-
primer: Km 0.0260.004 mM, kcat 2.360.15 min21 and kcat/Km
115 mM21 min21. As expected, no activity was observed with
dAMP (result not shown), as has been demonstrated previously for
HIV-1 RT [16]. The incorporated nucleotide could be further
extended by RT in the presence of all dNTPs, and the reaction
was template-dependent (data not shown). We believe that this is
the first demonstration that HIV-1 RT can use a nucleoside
diphosphate as a substrate for DNA synthesis.
The primer extension assays were performed using commer-
cially available, HPLC purified, deoxyadenosine di- and triphos-
phates, further purified by ion exchange chromatography.
However, the possibility that the dADP-dependent polymerase
activity was due to dATP contamination in the dADP stock
remained. To exclude this possibility, single nucleotide primer
extension assays were performed with the 39–59 deficient
derivative of Klenow fragment from DNA Pol I (KF exo-). KF
exo- was used as a negative control because DNA Pol I has been
Figure 1. Interactions between the dNTP substrate and RT. A. Representation of the active site highlighting fingers subdomain residues
involved in binding of the incoming nucleotide or AZT resistance. B. Detailed view of the interactions between the Lys65 residue, the incoming
nucleotide and the catalytic metal ions. Metal ion coordination is depicted with a dashed purple line, hydrogen bonds with an orange line. Figures
were generated from the published HIV-1 RT ternary structure (1rtd) [4] using the UCSF Chimera package [50].
doi:10.1371/journal.pone.0002074.g001
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demonstrated to be incapable of using a deoxynucleoside
diphosphate substrate [17]. Under conditions in which activity
was detected using RT, no extension was seen using KF exo-,
demonstrating the absence of significant dATP contamination
(Fig. 2B). Similar experiments were carried out utilizing FPLC
purified dCDP, dGDP and dTDP (Fig. 2C) which showed that
RT, but not Kf exo-, was capable of using each of the four dNDPs
as substrates opposite the corresponding complementary template
base. To exclude the possibility that the purified RT was
contaminated with either a nucleotide or a kinase capable of
phosphorylating the dADP to dATP, the dADP was treated by
pre-incubation with the RT preparation, heat-treated to inactivate
RT, and the material was used as a source of nucleotide in a
primer extension assay by KF exo- (Fig. 2D, see RT+dADP lane).
Again, no dADP-insertion activity was seen, demonstrating that
the dADP utilization by RT was not due to a contamination in the
enzyme preparation itself.
Lysine residue in the fingers subdomain (K65) is essential
for utilization of dNDPs
We previously demonstrated that the K65 residue, which
interacts with the c-phosphate of the incoming dNTP (Fig. 1), is
not essential for normal polymerization activity. In the context of
an incoming nucleoside diphosphate, the K65 residue may be
Figure 2. Utilization of a deoxynucleotide diphosphate substrate by HIV-1 RT. A. 59 end-labeled primer, annealed to a template strand,
was extended in the presence of a range of dADP concentrations by HIV-1 RT. The primer is extended by a single nucleotide, corresponding to the
template ‘T’ at the +1 position. Extension reactions contained 10 nM wild-type enzyme, 5 nM primer-template, and were carried out for 10 minutes.
Unextended primer is labeled ‘p’, the single nucleotide extension product is ‘p+1’. B. Single nucleotide extension assays of HIV-1 RT or KF exo- (50 nM
each) with 10 mM of either dADP or dATP demonstrated no activity in the reaction containing KF exo- and dADP. Lane B, unextended primer. C.
Single nucleotide extension assays utilizing dADP, dCDP, dGDP and dTDP incorporation opposite the complementary template nucleotide. Reactions
were carried out with 100 mM of the appropriate dNDP or 0.2 mM dNTP, 50 nM enzyme and 5 nM template-primer. Lanes B1 and B2 contained RT and
KF exo- respectively, with no nucleotide added. D. The RT preparation does not contain a contaminating nucleotide kinase activity. Nucleotides,
which had been pre-incubated in the presence (labeled RT+ADP) or absence of HIV-1 RT, were used in a single nucleotide extension assay with either
KF exo- or HIV-1 RT. Lane B: pre-incubation reaction contained no nucleotide. Unextended primer and primer extended by a single nucleotide are
indicated ‘p’ and ‘p+1’ respectively.
doi:10.1371/journal.pone.0002074.g002
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incapable of interacting with the shortened tail of a nucleoside
diphosphate, and thus be entirely dispensable for activity.
Therefore, we tested the nucleoside diphosphate insertion activities
of K65 substitution mutant RTs in a single nucleotide extension
assay. Three mutant RTs were tested including one with the
conservative K65R substitution, and two non-conservative K65A
and K65Q substitutions. No activity was detected with any of the
mutants (Fig. 3A), suggesting that the lysine residue at position 65
is essential for the activity utilizing a nucleoside diphosphate. In
order to assess whether the effect of the K65R substitution on
dADP utilization is directly related to dADP-binding, dead-end
complex (DEC) assays were performed (Fig. 3B). In the DEC
assay, the formation of a stable complex between the enzyme and
a primer-template in which the 39 terminus is blocked is measured
as a function of nucleotide concentration. Using this assay, the
K65R substitution was demonstrated to have no gross effect on
dADP binding, suggesting that this mutation did not have gross
changes in the dNTP-binding pocket and that the observed lack of
activity may be more directly related to the catalytic step. No
binding could be detected with the K65A or K65Q mutant
enzymes in the presence of dADP at 250 mM, the highest
concentration used in our DEC assays for K65R mutant (result not
shown). These results suggest that a basic residue at position 65 is
necessary for dNDP-binding.
HIV-1 RT catalyzes the inorganic phosphate-mediated
phosphorolysis to release dNDP
Pyrophosphorolysis is the reverse of a polymerization reaction.
While the forward reaction utilizes nucleoside triphosphate as the
substrate, in the reverse reaction the newly formed primer (n+1)
and pyrophosphate are used to regenerate dNTP and primer (n).
The substrate for the reverse reaction of dADP utilization should
be the inorganic phosphate and primer (n+1) to regenerate dADP
and primer (n) (Fig. 4A). Therefore, we looked for inorganic
phosphate-dependent (Pi-dependent) phosphorolysis of the 39-
terminal nucleotide from the primer DNA strand. Incubation of
wild-type RT with template-primer, in the absence of deoxynu-
cleotides, demonstrated the Pi-dependent removal of the terminal
nucleotide from the radiolabeled primer (Fig. 4B). Significantly
reduced Pi-dependent phosphorolysis was seen in reactions
containing KF exo-, consistent with previous results that
demonstrated an absence of Pi-dependent phosphorolysis in E.
coli DNA Pol I [17]. In order to demonstrate that the Pi-dependent
phosphorolysis was not due to a contamination of the reaction
with pyrophosphate, the primer was 39 labeled with [a-32P] TTP,
and the nucleotide products of the phosphorolysis reaction
analyzed by thin layer chromatography. If the Pi-dependent
phosphorolysis observed was mediated by the contaminating PPi,
the product released should be [a-32P] TTP, not [a-32P] TDP.
The results clearly showed that the major product of Pi-dependent
phosphorolysis was, as predicted, thymidine diphosphate (TDP),
and that this product was not liberated in reactions containing
Klenow fragment (Fig. 4C). Control reactions (lanes labeled PPi)
showed that TTP was produced in pyrophosphorolysis reactions
by both HIV-1 RT and KF exo-.
Reverse transcriptase containing the conservative K65R
mutation was capable of limited phosphorolysis, however the
nonconservative K65A and K65Q mutations abolished the
activity (Fig. 5). Thus, the ability of these mutants to insert dADP
correlates with their abilities to catalyze the reverse reaction–Pi-
dependent phosphorolysis.
Inorganic phosphate can be a donor for AZT-excision by
HIV-1 RT
HIV resistance to AZT is commonly associated with a cluster
of mutations in the reverse transcriptase, known as TAMs
(thymidine analog mutations). These mutant RTs lead to
resistance by increasing the efficiency of excision of the chain-
terminating AZT monophosphate from the terminus of the
nascent DNA chain by ATP-mediated phosphorolysis. The
TAM3 (M41L/L210W/T215Y) and TAM4 (D67N/K70R/
T215F/K219Q) enzymes were capable of using a dADP
substrate (Fig. 6A) and efficiently performed the Pi-dependent
phosphorolysis reaction (Fig. 6B and 6C). These enzymes were
assayed for primer rescue activity, a test of their ability to remove
a chain-terminating inhibitor, using inorganic phosphate as the
donor. As shown in Figure 7, the wild-type and both TAM
reverse transcriptases were capable of Pi-dependent primer
rescue. In the wild-type enzyme, the Pi-dependent recovery was
more efficient than ATP-dependent phosphorolysis, but far less
efficient than pyrophosphorolysis. As expected, the TAM RTs
showed increased utilization of ATP, compared to wild-type use
of ATP as a donor in the primer rescue experiment. However,
the TAM enzymes were less efficient than the wild type enzyme
in Pi-dependent rescue (Fig. 7B). Nevertheless, Pi dependent
activity contributed significantly to primer rescue by the TAM
enzymes.
Figure 3. Mutations at the lysine 65 position abrogate dADP
utilization. A. Single nucleotide extension assays were performed as
in Figure 2A, but with enzyme concentrations of 10 nM and 2 nM for,
respectively, dADP and dATP utilization. In both groups, the nucleotide
concentration was 100 mM. B. Nucleotide binding measured by DEC
formation. Reactions contained 20 nM wild-type or K65R mutant RT,
and 2 to 250 mM dADP. After challenge with competitor DNA, reactions
were separated by PAGE. Position of the complex is indicated. ‘P-T’
represents primer-template and ‘P’ is the unannealed primer. Reaction B
contained no dADP.
doi:10.1371/journal.pone.0002074.g003
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Discussion
Our results demonstrate that HIV-1 reverse transcriptase can
utilize a deoxynucleoside diphosphate substrate in the polymeri-
zation reaction. Although the reaction is less efficient than
polymerization using a deoxynucleoside triphosphate substrate,
we demonstrate that the activity is an inherent property of the RT,
and is not due to either the dATP contamination of the dADP, or
a kinase contamination of the RT preparation. Evidence that the
dADP preparation was not contaminated with dATP included
FPLC analysis and the absence of this activity in KF exo- reactions
with dADP. We have shown that incorporation by HIV-1 RT is
detectable with a dADP concentration of 100 nM (Fig. 2A); no
activity is seen with Kf exo- even at 10 mM dADP (Fig. 1B).
Further, we demonstrated that the RT also performs Pi-dependent
phosphorolysis and Pi-dependent excision of AZT.
Our data are surprising in that there is considerable evidence
that the c-phosphate of a dNTP is critical for nucleotide binding to
RT. Substantial interactions involving the dNTP c-phosphate, the
RT bound catalytic metal ion, and residues K65 and D113 of RT
were suggested by the crystal structure of RT-template/primer-
dNTP ternary complex [4]. Interactions between the c-phosphate
of the incoming nucleotide and the polymerase active site have
been shown to be crucial for stable nucleotide binding in both
human DNA polymerase a and the E. coli Klenow fragment; much
increased binding of nucleotide triphosphates was observed
compared to diphosphates or monophosphates [18,19]. Interest-
ingly, this difference in affinity was only observed for comple-
mentary nucleotide addition, suggesting that addition of the
correct nucleotide induced a conformational change in the
protein, and that the c-phosphate plays a crucial role in this
conformational change. Further evidence for the role of the dNTP
c-phosphate in binding and positioning of the dNTP for DNA
synthesis has been provided by mutation of the K65 residue to
abolish the interaction [5] and by modification of the nucleotide c-
phosphate [20]. In both cases, increased fidelity resulted from
reducing or abolishing the interaction between RT and the c-
phosphate. In the absence of the non-informational interaction
between RT and the c-phosphate, the nucleotide binding is
hypothesized to be dependent on other, sequence-specific
interactions between the incoming nucleotide and the enzyme [5].
Previous reports of a DNA polymerase utilizing a deoxynucleo-
side diphosphate as a substrate in a template dependent manner
are sparse. Kornberg’s group reported the unprimed DNA
Figure 4. Pi-dependent phosphorolysis catalyzed by HIV-1 RT. A. Diagram showing that pyrophosphorolysis and Pi-dependent
phosphorolysis are the reverse reaction of polymerization in which the substrate is a nucleotide triphosphate or diphosphate, respectively. B. Time
course of phosphorolysis and pyrophosphorolysis reactions catalyzed by HIV-1 RT and KF exo-. Reactions were performed with 5mM PPi or K2HPO4,
10 nM enzyme and 5 nM template-primer. Aliquots of the reaction were stopped after 1, 2 and 5 minutes and analyzed by denaturing PAGE. Lane B
contained a ‘no phosphate’ control in which template-primer was incubated with RT for 20 minutes. Full-length, 59-end labeled primer is indicated
‘p’, phosphorolysis products shortened by a single nucleotide from the 39 end are indicated ‘p-1’. C. Radiolabeled nucleotide products released from
the primer 39 terminus through a phosphorolysis reaction were separated by PEI-cellulose TLC. HIV-1 RT or KF exo- (5 nM) were incubated with primer
template in the presence of 10 mM Pi or 150 mM PPi, and aliquots removed after 2.5, 5 and 15 minutes. Lanes B1 and B2 contained control reactions
incubated for 15 minutes with RT and KF exo- respectively, in the absence of added phosphate. The position of TTP and TDP was determined by
comparison to unlabeled standards.
doi:10.1371/journal.pone.0002074.g004
Figure 5. Influence of K65 substitutions on Pi-dependent phosphorolysis. A. Pi-dependent phosphorolysis is inhibited by substitutions of
K65. 59-end labeled primer was incubated with RT (10 nM) and a range of inorganic phosphate concentrations. Lane ‘B’ contained no enzyme, lane 0
contained no Pi.
doi:10.1371/journal.pone.0002074.g005
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synthesis of an alternating dAT polymer, which was more efficient
with dADP than dATP [21]. Subsequently, a dADP transferase
activity was reported in some preparations of E. coli DNA
polymerase I, which synthesized poly dA-dT without requiring a
template or primer, apparently using dADP as the substrate [22].
More recently, it has been reported that the phage RB69 DNA
polymerase is capable of using a dNDP substrate, although the
reaction times were considerably longer than those reported here
for HIV-1 RT [9,23]. The crystal structure of this DNA
polymerase revealed that the phosphate groups of the incoming
nucleotide were stabilized in a similar manner to that found in
HIV-1 reverse transcriptase; the phosphates are sandwiched
between two divalent cations and three basic side-chains [24].
However, there is a significant difference in interactions between
the phosphate groups and the enzyme in the course of nucleotide
binding by RT, compared to the above polymerases; while RT
stabilizes nucleotide binding by interactions involving the b3–b4
loop, the corresponding structure in polymerases from family A
and B is an a helix [10].
Utilization of dADP as a substrate by HIV-1 RT is clearly much
less efficient than its use of dATP; there are numerous probable
factors involved in this reduced activity. First, the nucleoside
diphosphate is bound with a much lower efficiency than the
triphosphate nucleoside. In a ternary complex formation assay, the
apparent dissociation constant (Kd,app) for dADP was greater than
100 mM (Fig. 3B); by contrast, a similar experiment in which
binding of dATP was measured demonstrated a Kd,app of
approximately 9.2 mM [5]. Second, one of the two metal ion
binding sites in the polymerase domain of HIV-1 RT (site B) is
filled by a metal ion coordinated by the a, b and c phosphates of
the incoming nucleotide [4,25,26]. However, in the case of a
nucleoside diphosphate, this coordination by the a and b
phosphates of the nucleotide may lead to a positioning that is
initially incorrect for catalysis, and rearrangement of metal ion-RT
residue coordination may be needed for the reaction to proceed.
Precedence for such a rearrangement comes from E. coli creatine
kinase in which the metal ion rearranges from a b,c to a,b
coordination with the bound nucleotide [27]). An additional affect
on the catalysis step may be due to alteration in the geometry of
the b phosphate in the active site, affecting the formation of a
catalytically important, but nonessential, hydrogen bond between
a non-bridging oxygen on the b phosphate and the 3’OH of the
incoming nucleotide (Fig. 1B) [28]. Finally, the metal ion in
polymerase site B, coordinated with the b and c phosphates, is
proposed to enable the expulsion of the pyrophosphate leaving
group [29]. This could be less efficient when the substrate is
dADP, and the leaving group is Pi.
When DPO4, a polymerase from the Pol Y family, was
crystallized with ddADP in the active site, the a-phosphate of the
nucleotide was in the position that would normally be occupied by
the c-phosphate of a nucleotide triphosphate [30]. This arrange-
ment would prevent nucleotidyl transfer, and so cannot be the case
with dADP in the wild-type HIV-1 RT active site. Instead, it
would appear that to some extent the a and b-phosphates of the
dADP are coordinated similarly to their position when dATP is the
substrate, as polymerization can occur. In polymerase b it has
been suggested that triphosphate-sugar binding occurs before
there is a check for complementarity in nucleotide insertion [31].
Subsequently, it has been demonstrated that the tridentate
coordination of the nucleotide phosphates by the nucleotide-
binding metal ion occurs in an ordered manner; the initial
electrostatic interaction is with the c-phosphate, followed by the b
and a in turn. Our data suggests that this order is not necessarily
rigid and that the c-phosphate of the incoming nucleotide is not
absolutely required for the nucleotidyl transfer to take place.
Substitutions of K65, the residue that ordinarily interacts with
the c-phosphate of the incoming nucleotide, have a dramatic affect
on dADP utilization (Fig. 3A). We initially hypothesized that the
K65 residue is essential because the lysine residue is required to
interact with the b phosphate of the incoming dNDP, and that the
K65R substitution abolishes the interaction, thus the deoxynucleo-
side diphosphate cannot be bound in the active site. However,
using the dead end complex assay we demonstrated that the K65R
mutation has no obvious effect on dADP binding (Fig. 3B),
suggesting that the substitution instead directly affects catalysis.
With a nucleoside triphosphate substrate, Selmi et al. demonstrat-
ed that the conservative K65R mutation has no affect on
nucleotide binding, but it has a small affect on catalytic efficiency
through reduction of the catalytic rate constant kpol. This
reduction in efficiency is vastly increased, compared to the wild-
type, with a dideoxynucleotide substrate. In the dideoxynucleotide,
there is no hydrogen bond between the sugar and the non-
bridging oxygen on the b phosphate of the incoming nucleotide
(due to the absence of the sugar 39 OH) and, as discussed above,
absence of this interaction has a significant influence on catalysis
[28]. Structural evidence (Sarafianos, S.G., personal communica-
tion) supports the specific affect of the K65R substitution on
catalysis; in the absence of the stabilizing interaction between the
3’OH and the b phosphate of the nucleotide, R65 interacts instead
with the a phosphate and the R72 residue, directly affecting
catalysis. We speculate that this affect on kpol may also be seen
Figure 6. TAMmutants utilize dADP and perform Pi-dependent
phosphorolysis. A. Single nucleotide insertion assays performed with
100 mM nucleotide and 10 nM or 2 nM each enzyme, for dADP and
dATP reactions respectively. ‘p’ indicates unextended primer and ‘p+1’,
the single nucleotide extension product. B. Pi-dependent phosphorol-
ysis reactions contained 10 nM each enzyme, and 0, 0.1, 1 or 10 mM Pi.
Full length 59 end labeled primer is indicated ‘p’, primer with a single
nucleotide excised from the 39 end is shown as ‘p-1’. C. Time course
reactions for the Pi-dependent phosphorolysis contained 10 nM each
enzyme and 10 mM Pi.
doi:10.1371/journal.pone.0002074.g006
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when dADP is the substrate, if the 3’OH-b phosphate stabilizing
bond is no longer formed with this nucleotide.
The reverse reaction of polymerization utilizing a dNTP
substrate is pyrophosphorolysis. In an analogous manner, Pi-
dependent phosphorolysis is the reverse reaction of dADP
utilization. We have shown that RT is capable of performing Pi-
dependent phosphorolysis, and confirmed that the released
product is, as expected, a nucleoside diphosphate (Fig. 4). As far
as we are aware, this is the first demonstration of Pi-dependent
phosphorolysis by a DNA polymerase. The most similar reported
activities are pyrophosphorolysis by HIV-1 RT using either
hypophosphoric acid [32] or phosphonoacetic acid [33] as a
substrate. DNA-dependent RNA polymerase from E. coli has also
been shown to catalyze the release of a nucleoside monophosphate
from a DNA strand when the phosphate donor is a pyrophosphate
analog containing an arsono group [34]. Additionally, as the RB69
DNA polymerase can utilize a nucleoside diphosphate substrate
for polymerization [9,23], it is probable that it can catalyze Pi-
Figure 7. Pi-dependent primer unblocking by wild type and TAM mutants. 59 end labeled primer was blocked with AZT, followed by
incubation with a phosphate donor (Pi, ATP or PPi) and dNTPs. Unblocked primer is extended to the end of the template, resulting in the ‘full length’
product. Control lanes C1, C2 and C3 contained no phosphate donor, no dNTPs and no AZT respectively. B. Graphical representation of the results
from three independent primer unblocking experiments. Error bars show the standard deviation of the results.
doi:10.1371/journal.pone.0002074.g007
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dependent phosphorolysis, but to our knowledge this has not been
demonstrated. We observed a reduction in Pi-dependent phos-
phorolysis in the K65R mutant RT, and no observable
phosphorolysis in the non-conservative substitutions. Although
the K65R mutation is associated with AZT resistance in vitro [35],
the mechanism for this resistance is through reduced efficiency of
incorporation of the analog. The K65R mutation has been
demonstrated to decrease pyrophosphorolysis [6] and ATP-
dependent primer rescue [36], and re-sensitizes viruses carrying
the TAM mutations to AZT [37,38].
The concentration of inorganic phosphate (Pi) required to observe
Pi-dependent phosphorolysis in vitro (1 to 10 mM) is within the range
expected intracellularly. The intracellular Pi concentration varies
according to both cell type and extracellular phosphate concentra-
tion, within a range of 0.7 to 3 mM [39,40]. The intracellular
pyrophosphate (PPi) concentration is typically stated to be between
120 and 150 mM in human lymphocytes [41]. However, recent data
has shown that the PPi concentration is actually much lower; between
8 to 12 mM in unstimulated T cells, and between 55 to 79 mM in
highly stimulated T cells [42]. RT-catalyzed phosphorolysis and
primer rescue are observed in vitro even using these lower
concentrations of PPi. Furthermore, recent work has shown that
HIV-infected patients suffer from severe biochemical abnormalities,
including hypophosphatemia [43]. The possible influence of these
biochemical abnormalities on intracellular concentration of phos-
phate and phosphate-containing molecules is unknown.
We have also demonstrated that HIV-1 RT can mediate Pi-
dependent primer rescue, and that the wild-type enzyme utilizes
inorganic phosphate and ATP to a similar extent in this reaction.
However, it is clear that the increase in chain-terminating
nucleoside excision by the TAM mutants when using ATP as a
substrate is not observed when using Pi as a substrate. It is possible
that other TAM mutations (including those not tested here, as well
as those that are as yet undiscovered) in the reverse transcriptase
could enhance Pi-dependent primer rescue, and thus have
important consequences in vivo. This would be analogous to the
enhancement in efficiency in utilization of ATP as a substrate for
AZT resistance by the TAM mutants compared to the wild-type
enzyme. Obviously, mutations in HIV-1 RT that enhance
nucleotide excision via Pi-dependent phosphorolysis have not
been identified to date.
Meyer et al. demonstrated that many different nucleotides,
including deoxynucleotides and nucleoside diphosphates, have the
potential to be used by HIV-1-RT as a phosphate donor for the
excision of AZT [11]. RT has been previously shown to use either
PPi or ATP as a phosphate donor for excision of AZT from a
chain terminated primer in vitro at physiologically relevant
concentrations [42]. Circumstantial evidence suggests that ATP
is the in vivo donor, as only excision using ATP as the donor is
enhanced in the TAM RTs [13], and the TAM mutants are
associated with AZT resistance in cell culture-based HIV
replication assays. However, the nucleotide resulting from PPi
dependent excision of AZT is AZT-triphosphate, and from ATP-
dependent excision is a dinucleoside tetraphosphate (AZTp4A).
AZT-triphosphate is obviously a substrate of the RT, and
dinucleoside tetraphosphates have also been shown to be
substrates for DNA chain elongation by RT [44]. More recently
the nucleotide product of AZT excision, AZTp4A, was also
specifically shown to be an efficient substrate for RT [45]. If a
variant RT were to utilize inorganic phosphate as the phosphate
donor in AZT excision, the released nucleotide would be AZT-
diphosphate. The data we have presented in this paper show that
RT can use a nucleoside diphosphate as a substrate for elongation,
but with a much lower efficiency than a nucleoside triphosphate.
This raises the possibility that a Pi-dependent excision mechanism
could be an efficient mechanism for the removal of chain-
terminating nucleotide analogs by HIV-1 RT.
Materials and Methods
Nucleotides, oligonucleotides and commercial enzymes dADP, dCDP,
dGDP, dTDP (dNDPs) and dAMP were purchased from MP
Biomedicals. AZTTP was purchased from Moravek Biochemicals.
In experiments comparing polymerase activity with dAMP, dNDP
and dATP, the nucleotides were further FPLC purified as
described below. Primers (Invitrogen and IDTDNA) were gel
purified. Nucleoside triphosphates were purchased from CLP
(Mercury Ultra-Pure nucleotides). Exonuclease negative Klenow
fragment (KF exo-) was purchased from NEB. ATP and sodium
pyrophosphate were purchased from Sigma-Aldrich. Inorganic
pyrophosphatase was purchased from Roche.
Protein purification
All proteins, except the TAM mutants, were purified as
described in Garforth et al.[5]. The construction of expression
plasmids and the purification of TAM mutant RTs was previously
described [12,46].
Purification of dAMP, dNDPs and dATP
Purification of the nucleotides was carried out using an A¨kta
Explorer (Amersham Biosciences) at room temperature. A
1.25 mM solution of each nucleotide (250 ml) was applied to a
Mono Q HR 5/5 column in 10 mM Tris, pH 8.0. The
nucleotides were eluted from the column with a linear gradient
from 0 to 200 mM NaCl in 40 column volumes. Peak elution of
the nucleotides was at a NaCl concentration of 60 mM, 110 mM
and 130 mM for dAMP, dADP and dATP respectively. The peak
fractions, approximately 2 ml total for each nucleotide, were
combined, quantified by spectrophotometry and used in the single
nucleotide insertion assay.
Single nucleotide insertion assays
Polymerase assays measuring the extension of a primer by a
single nucleotide were carried out essentially as described [5].
Briefly, a 59 32P end-labeled primer (59 ACGCCAGGGTTTT-
CCCAGTCACGACGTTGTAAA 39) was annealed to the
oligonucleotide Template1 (59 CCCGXTTTACAACGTCGT-
GACTGGGAAAACCCTGGCGT 39) at a 1:1.5 molar ratio. The
residue indicated with ‘X’ (in bold) in the sequence was
complementary to the incoming nucleotide. Different oligonucle-
otides with each of the four nucleotides at this position were
employed. Enzyme (10 nM) and template-primer (5 nM) were
incubated together in reaction buffer A (50 mM Tris-HCl
(pH 8.0), 80 mM KCl, 6 mM MgCl2, 1 mM DTT, 0.1 mg/ml
ultra-pure BSA (Ambion)) and a single nucleoside (either dATP or
dADP, concentration specified in the figure legends). The reaction
products were separated on a denaturing 10% acrylamide
sequencing gel, and exposed to a PhosphorImager screen. In
single nucleotide insertion assays using pre-treated nucleotides, the
nucleotide added to the primer extension reaction was first
incubated at 37uC for 15 minutes in reaction buffer A containing
250 mM dADP or 10 mM dATP, and RT (as required) at a
concentration of 10 nM. The pre-incubation reactions were heat
treated at 90uC for 3 minutes, and then added to extension assays
such that the final nucleotide concentration was 50 mM (dADP)
or 2 mM (dATP). The extension assays were performed in reaction
buffer A, and contained 20 nM of HIV-1 RT or KF exo-
incubated at 37uC for 15 minutes.
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Dead End Complex (DEC) formation
Reactions were performed essentially as described previously
[5]. Briefly, primer (identical sequence as above) was 59 end
labeled with 32P, and blocked at the 39 end with ddADP. The
primer was annealed to Template2 (59 CGCAGTATCCCGTTT-
TACAACGTCGTGACTGGGAAAACCCTGGCGT). 20 nM
enzyme was incubated at 37uC for 5 minutes with 0.1 nM
template primer in buffer A, DEC formation was initiated by
the addition of dADP and the reaction incubated for a further
10 minutes. Finally a half volume of competitive trap mixture
(12 mg/ml poly rA and 3 mg/ml oligo(dT) in 10 mM Tris, pH 8.0,
100 mM KCl, 30% glycerol and 50 mg/ml bromophenol blue)
was added, the reactions were incubated for 5 minutes at 37uC,
and then placed on ice. Reactions were analyzed by 6% native
PAGE in 0.5x TBE, and visualized with a PhosphorImager.
Phosphorolysis
Inorganic phosphate- and pyrophosphate-dependent phospho-
rolysis were analyzed by measuring the removal of the 39 terminal
nucleotide from a 59 end-labeled primer, and separating the
reaction products by 10% denaturing PAGE. Reactions were
essentially as described for single nucleotide extension assays, but
with no added nucleotide. Inorganic phosphate (K2HPO4) or
sodium pyrophosphate was added to each reaction as described in
the Figure legends. In order to analyze the phosphorolysis
reactions by TLC, primer-Template1 described above was first
annealed at a molar ratio of 1:2, and labeled in a reaction
containing 20 pmol primer, 40 pmol template, 60 mM Tris
pH 8.0, 50 mM KCl, 6 mM MgCl2, 1 mM DTT, 0.1 mg/ml
BSA, 120 mCi a32P TTP (3000 Ci/mmol, 10 mCi/ml) and 5 units
KF exo- in a volume of 40 ml. The reaction was incubated at 37uC
for 30 minutes, then heat inactivated at 80uC for 10 minutes. The
KCl concentration was increased to 100 mM, and the primer-
template annealed by slow cooling to room temperature. The
annealed primer-template was separated from unincorporated
radiolabeled TTP using a Micro Bio-Spin 30 column (Bio-Rad),
which was pre-equilibrated with 20 mM Tris, pH 8.0, 100 mM
KCl. The primer-template concentration was measured by
scintillation counting, and used at a concentration of 5 nM in
phosphorolysis reactions containing 10 nM wild type HIV-1 RT
or KF exo-. With the exception of the primer-template, reaction
components were identical to the PAGE-analyzed reactions.
Reactions were initiated by the addition of K2HPO4 to a
concentration of 10 mM, or 150 mM PPi, incubated at 37uC,
and aliquots were removed at time intervals and stopped by the
addition of EDTA to 23.3 mM. 2.5 ml of each stopped aliquot was
applied to a fluorescent cellulose-PEI TLC plate (Selecto
Scientific) and developed for 2.5 hours in 0.2 M K2HPO4,
0.35 M boric acid, 50 mM EDTA (modified from [47]). The
samples were visualized by exposure to a PhosphorImager screen,
and identified by comparison to unlabelled TDP and TTP
standards, which were visualized by fluorescence.
Primer rescue
Deoxynucleotides, AZTTP and ATP were treated with
inorganic pyrophosphatase (Roche) essentially as described [48],
except that pyrophosphatase was removed by filtration through a
Vivaspin 500 10k MWCO ultrafiltration unit (Vivascience).
Primer rescue experiments were performed using a protocol
similar to that in Mas et al. [49]. Five nanomolar primer-template
(primer as described above, template sequence 59 CGCAG-
TATCCCGATTTACAACGTCGTGACTGGGAAAACCCTG-
GCGT) was blocked by incubation (10 minutes, 37uC) with
10 nM HIV-1 RT (wild-type or mutant, as specified) and 5 mM
AZTTP in reaction buffer B (reaction buffer B was similar to
buffer A, but contained 32 mM KCl). Primer recovery was
initiated by simultaneous addition of 10 mM dNTPs and PPi,
K2HPO4 or ATP as specified, and extended for 10 minutes at
37uC. Reactions were stopped by addition to 1.5 volumes 95%
formamide loading buffer, and separated by denaturing 10%
PAGE. The reaction products were visualized by exposure to a
PhosphorImager screen.
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